• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CARDIOVASCULAR SYSTEMS CORPORATION STERILE FX25REC W/RES BLOOD GAS OXYGENATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CARDIOVASCULAR SYSTEMS CORPORATION STERILE FX25REC W/RES BLOOD GAS OXYGENATOR Back to Search Results
Model Number 3CX*FX25REC
Device Problem Gas Output Problem (1266)
Patient Problem Lactate Dehydrogenase Increased (4567)
Event Type  malfunction  
Manufacturer Narrative
Terumo has not received the device for evaluation; therefore, the investigation has yet to be completed. Terumo plans on submitting a follow-up report when the investigation is complete and when more information becomes available.
 
Event Description
The user reported to terumo cardiovascular during cardiopulmonary bypass the performance of the oxygenator decreased to po2 of 90 after 6. 5 hours of bypass. As per user facility, the case ended up being a redo aortic root replacement/pa conduit implantation. All acts were kept in the 400-500 range, act right before change out was 416. Additional heparin administration on bypass was limited due to sufficient acts most of the case. Not much heparin resistance was observed. As per ccp he was told pre-cpb and early cpb lactate was elevated, at least 10. The patient had pao2s in the 300-400s at about 50 fio2 at the peak cold set point of 28 degrees c, also the sweep averaged around 5 with a heavy -10 base deficit during this coldest point and a higher 40s paco2. Lactate now 14. It was during rewarm that the pao2 started to drop with great fio2 increase to eventually 100 percent. The sweep also had to eventually be raised to 9-10 with climbing paco2 values. Lactate also rose throughout the case with the last lactate being 20 before patient left the room. At pao2 of about 95-100 and fio2/ sweep maxed, all connections of cpb ventilation were checked then the oxygenator was connected directly to tank, different arterial sample locations were drawn and radial which reflected similar values. Pao2 coasted at 85 right before the circuit change out occurred. Pao2 rose to 500s with new circuit. The last venous saturation that was observed before circuit change was low 60s and patient pre change out was about 10-11 hgb and post change out was low 9 hbg. For the change out, the new circuit was decided to be primed with 2 rbcs and 1 of ffp, chasing plasmalyte prime volume out, the change out occurred during rewarm period at the 32-34 degree mark. In addition according to ccp, the high complexity of the case resulting in a longer bypass time (circuit change out occurred at the 6 hour and 40min mark) and the advanced lactate/ metabolic and respiratory acidosis throughout, the oxygenator had an excessively high settings for a long period of time which were the main factors. After draining the old circuit, no clots were visible anywhere around the oxy nor the reservoir. There was minimal blood loss. There was 1-2 minute delay. The product was changed out. The surgery was completed successfully.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand NameSTERILE FX25REC W/RES
Type of DeviceBLOOD GAS OXYGENATOR
Manufacturer (Section D)
TERUMO CARDIOVASCULAR SYSTEMS CORPORATION
125 blue ball road
elkton MD 21921
Manufacturer (Section G)
SAME
Manufacturer Contact
jamie quinlan
125 blue ball road
elkton, MD 21921
8002837866
MDR Report Key11826411
MDR Text Key252017790
Report Number1124841-2021-00111
Device Sequence Number1
Product Code DTZ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K151791
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 06/25/2021
1 Device was Involved in the Event
0 Patients were Involved in the Event:
Date FDA Received05/14/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator
Device Model Number3CX*FX25REC
Device Catalogue NumberN/A
Device Lot NumberZD01
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/30/2021
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Event Location No Information
Date Manufacturer Received06/25/2021
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured03/01/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial

-
-